PFEIFER ANDREA,MUHS ANDREAS,MADANI RIME,BELICHENKO PAVEL VASILYEVICH,MOBLEY WILLIAM CHARLES
申请号：
NZ62265312
公开号：
NZ622653A
申请日:
2012.09.21
申请国别(地区):
NZ
年份:
2015
代理人:
摘要：
Disclosed is a use of an of an antigenic peptide fragment derived from amyloid protein or amyloid-like protein selected from the group consisting of prion protein, tau protein, alpha-synuclein, huntingtin and amyloid beta for the preparation of a medicament for use in the treatment, alleviation or prevention of memory and/or cognitive impairments or abnormalities in subjects with Down&rsquos syndrome wherein the subjects with Down&rsquos syndrome have not yet developed amyloid protein-associated or amyloid-like protein-associated, plaques in the brain.
